Methoxisopropamine
From Wikipedia, the free encyclopedia
(Redirected from MXiPr)
Chemical compoundTemplate:SHORTDESC:Chemical compound
Pharmaceutical compoundTemplate:SHORTDESC:Pharmaceutical compound
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C16H23NO2 |
| Molar mass | 261.365 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
MXiPr (Methoxisopropamine, Isopropyloxetamine, Isopropyxetamine') is a recreational designer drug with dissociative effects. It is an arylcyclohexylamine derivative, related to drugs such as ketamine and methoxetamine. It is an N-ethyl homologue to methoxetamine. Since it hasn't been extensively studied, the pharmacological effects are unclear, but its effects are reportedly similar to methoxetamine. It was first identified in Slovenia in December 2020,[1] and was made illegal in Hungary in April 2021.[2]
See also
[edit | edit source]References
[edit | edit source]
| |||||||||||||||||||||||||||||||||||||
| σ1 |
|
|---|---|
| σ2 |
|
| Unsorted |
|
See also: Receptor/signaling modulators | |
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Pages with script errors
- Articles with short description
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- All stub articles